PC
Pcotta
Community Contributor
Member since 2024
Views
2 Total number of views
Fair Values Set
0 Total number of fair values set
Comments
0 Total number of comments
Followers
0 Total number of followers
No bio added yet
No link added
The New Prime: Why Rocket Lab’s $1.8B Backlog and Neutron Debut Make it the Premier Space Growth Play of 2026
1. The "Space Systems" Engine The most misunderstood part of Rocket Lab is that it isn't just a rocket company.Read more
CR
€90.52
38.9% undervalued intrinsic discount
Fair Value
Profit Margin
17%
Future PE
120x
Price in 2029
€107.69
Hermès - Expensive bags, and expensive stock. And the story of €14 billion of bearer shares gone missing.
About Hermès International SA Hermès International SA is a French luxury goods manufacturer. Its core business is leather goods.Read more
CL
€1.51k
1.8% overvalued intrinsic discount
Fair Value
Revenue
3.65% p.a.
Profit Margin
28.27%
Future PE
43.4x
Price in 2031
€2.24k
Paradigm Biopharmaceuticals Will Lead Osteoarthritis Treatment with Zilosul's FDA Success
Paradigm Biopharmaceuticals is riding on a make‑or‑break moment as its osteoarthritis injection Zilosul moves through late-stage testing and awaits a key US regulator decision. If it works and gets cleared, it could offer a new option beyond today’s pain-focused treatments—but any trial or approval setback could quickly change the outlook.Read more